2-BENZOYL-8-METHYL-2,3-DIHYDROISOQUINOLINE-1-CARBONITRILE, 90.0%, 5g

N-Tosylbenzamide, 95.0%, 250mg

7-Bromo-2-methylimidazo[1,2-a]-pyridine-3-carboxylic acid, 97%, 250mg

3-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 98%, 250mg

7-Bromo-4-chloro-1-methyl-1H-indazol-3-amine, 97%, 1g

CDTA, min. 99%, for synthesis, 100 g, plastic packaging.

Methyl 5-oxo-4,5-dihydroisoxazolo[4,5-b]pyrazine-3-carboxylate, 95+%, 250mg

4-Chloro-3-nitro-pyridine, 97.0%, 25g

Ethyl 1-ethyl-4-methyl-1H-pyrazole-5-carboxylate, 98%, 10g

7-Ethynyl-dA-CEP, ≥90%, 100 mg, plastic packaging.

7-Bromo-1,5-naphthyridine-3-carboxylic acid, 95.0%, 250mg

Potassium Bis(trimethylsilyl)amide (ca. 22% in Tetrahydrofuran, ca. 1.0mol/L)100mL

Ethyl Benzoylformate>96.0%(GC)25mL